ANVS Annovis Bio, Inc.
1.170USD-2.50%Mkt Cap: 49.93M $P/E: —Today
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer's dise…
Industry Peers
Biotechnology$127.47BUSDP/E 29.3
$78.65BUSD
$76.14BUSDP/E 18.3
$51.48BUSDP/E 31.2
$48.23BUSDP/E 31.4
$41.82BUSDP/E 17.8
$40.32BUSD
$39.83BUSDP/E 62.6
$32.48BUSDP/E 29.9
$30.04BUSDP/E 37.9
$24.71BUSD
$23.13BUSD
$22.85BUSDP/E 14.4
$22.17BUSDP/E 28.4
$21.94BUSD
$21.10BUSDP/E 29.1
$14.65BUSDP/E 17.1
$14.62BUSDP/E 18.6
$14.44BUSDP/E 15.2
$13.70BUSD
Key Statistics
Company
Market Cap49.93M USD
Enterprise Value31.55M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-28.85M USD
Revenue/Share—
Last Price1.170 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.37
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-11.80
EPS (TTM)-1.72
EPS (Forward)-0.86
52W Range
1.0403% of range5.500
52W High5.500 USD
52W Low1.040 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-171.23%
ROA-136.87%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.62M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-47.65%
Net Debt-18.73M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio3.47
Quick Ratio2.94
Book Value/Sh-0.10 USD
Cash/Share0.44 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)10.50 USD
Upside (mean)+797.4%
Target Range7.000 USD – 17.00 USD
7.000+797.4% to mean17.00
# Analysts4
Ownership
Shares Out.42.68M
Float35.47M
Insiders11.79%
Institutions27.86%
Short Interest
Short Ratio5.1d
Short % Float15.48%
Short % Out.14.11%
Shares Short6.02M
Short (prev mo.)4.96M
Technical
SMA 501.540 (-24.0%)
SMA 2002.159 (-45.8%)
Beta1.23
S&P 52W Chg16.45%
Avg Vol (30d)1.16M
Avg Vol (10d)886.88K
Technical Indicators
RSI (14)38.6
MACD-0.0793
MACD Signal-0.0917
MACD Hist.+0.0124
BB Upper1.377 USD
BB Middle1.203 USD
BB Lower1.030 USD
BB Width28.86%
ATR (14)0.0896 USD
Vol Ratio (20d)0.82x